ImmunotherapyPatient SelectionSelection, GeneticImmunotherapy, AdoptiveImmunotherapy, ActiveDesensitization, ImmunologicTreatment OutcomeCancer VaccinesAntigens, NeoplasmClinical Trials as TopicNeoplasmsAdministration, SublingualTeaching RoundsSublingual ImmunotherapyRetrospective StudiesRhinitis, Allergic, SeasonalAntibodies, MonoclonalT-Lymphocytes, CytotoxicTime FactorsCombined Modality TherapyT-LymphocytesPostoperative ComplicationsDendritic CellsAllergensFollow-Up StudiesAntineoplastic AgentsPrognosisMelanomaInterleukin-2CD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingMice, Inbred C57BLSurvival RateCell Line, TumorCytotoxicity, ImmunologicRisk AssessmentMelanoma, ExperimentalLymphocyte ActivationImmunization, PassiveSurvival AnalysisFetal TherapiesHLA-A2 AntigenProspective StudiesPredictive Value of TestsMolecular Sequence DataPollenBee VenomsRisk FactorsLung NeoplasmsMice, Inbred BALB CModels, GeneticTumor EscapeClinical Trials, Phase I as TopicImmunoglobulin ERandomized Controlled Trials as TopicKidney NeoplasmsEvolution, MolecularCarcinoma, Renal CellReoperationEpitopes, T-LymphocyteNeoplasm Recurrence, LocalLiver NeoplasmsAntigens, PlantBCG VaccineMolecular Targeted TherapyAlzheimer VaccinesCD4-Positive T-LymphocytesMutationHypersensitivityCytokine-Induced Killer CellsRecurrenceTomography, X-Ray ComputedMice, TransgenicHLA-A24 AntigenAntibodies, NeoplasmInterferon-gammaGenetic VariationFlow CytometryInsect Bites and StingsHLA-A AntigensAdjuvants, ImmunologicRhinitis, Allergic, PerennialNeoplasm MetastasisBiological EvolutionNeoplasm StagingMelanoma-Specific AntigensSelection BiasNeoplasms, ExperimentalPreoperative CareHeart Valve Prosthesis ImplantationAmbulatory Surgical ProceduresStrokeProstatic NeoplasmsAmino Acid SequenceSurgical Procedures, Minimally InvasiveAntigen PresentationDisease-Free SurvivalReproducibility of ResultsKiller Cells, Naturalgp100 Melanoma Antigen